Efficacy of Black seed (Nigella sativa) in the management of Type 2 Diabetes

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR202310875852492

Enrollment

Registered

2023-10-03

Start date

2022-09-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nutritional, Metabolic, Endocrine

Interventions

nigella sativa group

B GROUP

control group Cgroup

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: All participants with Type 2 diabetes attending care at Gatundu Level 5 Hospital Non-communicable Disease Center who consented to participate and signed a written informed consent.

Exclusion criteria

Exclusion criteria: Type 2 diabetes patient attending care at Gatundu Level 5 Hospital Non-communicable Disease Center WHO HAD COMPLICATION SUCH AS RENAL FAILURE, STROKE. Those who did not consent

Design outcomes

Primary

Measure	Time frame
mean change in HbA1C 3 months post intervention	—

Secondary

Measure	Time frame
Mean changes in Lipid profile--Triglycerides, total cholesterol, high density lipo-protein and low density lipo-protein post intervention;mean changes in Tumor necrotic factor post intervention;mean change in antioxidant factor-vitamin C and glutathione level post intervention	—

Countries

Kenya

Contacts

Public ContactANN THUITA WAMBUGU

Jomo Kenyatta University of Agriculture and Technology

ann.thuita@jkuat.ac.ke+254721783766

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026